Get Started
Complete the short form belowto Contact a Nexel Medical physician
Both semaglutide and tirzepatide have been used for weight management and to treat obesity. Both medications began their lives as medications to treat type 2 diabetes — as Ozempic and Mounjaro, respectively. Semaglutide was the first drug of this kind to be approved for weight loss and obesity management.It has since been sold under the brand name “Wegovy. Tirzepatide was approved for weight management in November 2023 and has since been sold under the brand name “Zepbound.”
These are both very similar prescription medications and have many things in common in terms of effectiveness for weight loss, mechanisms of action, and side effects. However, they are not the same thing.
Both drugs belong to a class of groundbreaking weight loss drugs known as GLP-1 agonists, which work by mimicking glucagon-like peptide-1 (GLP-1), a natural hormone that is involved in regulating blood glucose levels as well as how long food remains in your stomach. Therefore, these drugs can be effective for weight loss by improving metabolism and impacting hunger, digestion, and feelings of fullness. Both Tirzepatide and Semaglutide are given via a once-weekly subcutaneous injection. Let’s take a close look at what the two drugs have in common and where they differ.
Both semaglutide and tirzepatide can be prepared as compounded medications in certain patient-specific situations when current medical and legal requirements are met. Compounding is the process of preparing a prescription medication specifically for an individual patient rather than dispensing a commercially manufactured product in its standard form. A licensed compounding pharmacy may prepare a medication in a different dose, concentration, or formulation when a healthcare provider determines that the patient has a specific need for that compounded preparation. This gives doctors another potential option when developing an individualized medical weight-loss program instead of assuming that every patient must receive exactly the same medication in exactly the same way.
Keep in mind that either drug is not merely an “appetite suppressant” or any kind of “diet pill” but a serious prescription drug researched and developed for medical weight loss purposes in specific target populations. Tirzepatide, in particular, has a unique mechanism of action and target audience among the class of GLP-1 agonists since it is the only one that also acts as a (GIP) receptor agonist.
Both tirzepatide and semaglutide are most commonly given as a subcutaneous (below the skin) injection using a pen-like injector device. To give this type of injection, you start by sterilizing the injection site with an alcohol swab. Then, pinch a fold of skin at the cleaned injection site to create a small area of tissue. Remove the cap of the injector pen of either device and carefully insert the needle into the fold of the skin at a 90-degree angle or as directed by your healthcare provider. Push the plunger down to inject the medication.
Either drug can be taken any time of day or night with or without food; the key is that you take your once-weekly injection at the same time each week.
A typical semaglutide dosage schedule for weight loss is:
Like semaglutide, tirzepatide is titrated, meaning your doctor will start you out at the lowest possible dose and slowly increase to the maximum effective dosage for weight loss.
Typically, the starting dosage of tirzepatide is 2.5 mg. In addition to the starting dose, Tirzepatide is available in 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Similar to Semaglutide, your doctor will probably increase your dosage monthly until you build to the maximum dose. In clinical trials, optimal weight loss was seen in patients on the 15mg dose of Tirzepatide.
Both semaglutide and tirzepatide are on the expensive side as prescription drugs go. But of the two, “name brand” semaglutide (Wegovy) is more expensive, with an average price of around $1600** for a one-month supply, whereas name brand tirzepatide (Zepbound) is about $1100**.
The price you pay for either drug will likely vary depending on whether you have insurance, your particular healthcare plan, and your pharmacy. Compounded versions of either drug can cost considerably less per month.
Tirzepatide and semaglutide work by mimicking the action of certain naturally occurring hormones that are involved in appetite and glucose metabolism. While the biological impact is similar, Semaglutide and Tirzepatide act somewhat differently because they mimic the effects of different hormones. Semaglutide mimics the action of GLP-1. Tirzepatide also acts like GLP-1 in the body, but in addition, it mimics the action of another hormone that Semaglutide does not, known as GIP.
The actions of both of these naturally occurring hormones and the drugs that mimic them can make you feel fuller quicker and longer, which can curb appetite and help you lose weight.
In the initial trials, tirzepatide seemed to be somewhat more effective for weight loss than semaglutide. People receiving the highest tirzepatide –15 mg — lost nearly 21% of their starting body weight on average. What’s more, almost 60% of participants in this group lost 20% or more of their body weight. In its initial approval trials, the maximum weight loss on Semaglutide was 16% of the participant’s total starting body weight.
A recently concluded head-to-head trial of the name brand drugs (Wegovy vs Zepbound) found that tirzepatide did deliver superior weight loss.
Besides the major differences between semaglutide and tirzepatide discussed above, there are a few other differences between the two. One of the clearest differences involves age. Wegovy, the semaglutide product approved for chronic weight management, can be prescribed for adults with obesity, adults who are overweight and have at least one weight-related health condition, and adolescents age 12 and older who have obesity. Zepbound, the tirzepatide product approved for weight management, is currently indicated for adults with obesity or adults who are overweight and have at least one weight-related condition. This means semaglutide currently provides a weight-management option for some younger patients for whom Zepbound is not approved.
The two medications also have different additional indications that may make one particularly relevant for certain adult patients. Wegovy, the brand name of semaglutide is prescribed to reduce the risk of major cardiovascular events, including cardiovascular death, heart attack, and stroke, in adults who already have cardiovascular disease and are overweight or have obesity. Semaglutide is also used for certain adults with metabolic dysfunction-associated steatohepatitis, or MASH, who have moderate to advanced liver fibrosis but do not have cirrhosis. Tirzepatide has a different additional indication; it is also prescribed to treat moderate to severe obstructive sleep apnea in adults with obesity.
For an adult who has obesity along with established cardiovascular disease, MASH, or significant sleep apnea, these additional indications may become part of the discussion when a provider is deciding which treatment offers the most appropriate overall fit.
It is not a question of which is best, it’s more of a question of “which is best for you.”
Both medications can be effective tools for helping appropriate patients lose weight by reducing hunger, improving feelings of fullness, and making it easier to control food intake. Semaglutide primarily works through the GLP-1 pathway, while tirzepatide works through both GLP-1 and GIP pathways, which is one reason patients may respond differently to the two medications. Your starting weight, weight-loss goals, health history, eating habits, previous weight-loss efforts, other medications, lifestyle, and ability to tolerate treatment can all play a role in deciding which approach makes the most sense in your particular case. Some patients achieve excellent results with semaglutide, while others may respond better to tirzepatide, which is why treatment should be based on the individual rather than on which medication happens to be receiving the most attention.
Choosing the right medication is also only the beginning of a successful medical weight-loss program. Your provider should continue to monitor how well the medication controls appetite, how much weight you are losing, how you tolerate the treatment, and whether your dosage needs to be adjusted as you progress. Nutrition, physical activity, sleep, and other healthy lifestyle habits can further support your results and help make weight loss easier to maintain over time. If one medication is not producing the response expected, your provider can reassess the program and determine whether a change in dosage, additional lifestyle support, or a different medication may be appropriate. The goal is not to prescribe the same drug to every patient; it is to create a personalized weight-loss program that gives you the best opportunity to reach and maintain your individual goals.
Whether you semaglutide or tirzepatide is best for you, you really have only one choice when it comes to medical weight loss: Nexel Medical.
At the Nexel medical clinics nationwide we do not believe in one-size-fits-all weight-loss programs or simply prescribing whichever medication happens to be popular at the moment. Your program begins with a medical consultation and evaluation so our healthcare providers can learn about your health history, previous attempts to lose weight, current lifestyle, medications, concerns, and personal weight-loss goals. When appropriate, your provider can also review laboratory testing and other health information to get a more complete picture of the factors that may be making weight loss difficult. From there, we can recommend a treatment plan built around your individual needs, whether that includes semaglutide, tirzepatide, or another medically appropriate approach.
Our commitment does not end when your prescription is written. Medical weight loss is an ongoing process, and your needs can change as you lose weight and your body responds to treatment. We provide continued medical supervision so your progress can be evaluated, your dose can be adjusted when appropriate, and questions or side effects can be addressed along the way.
If you are ready to lose weight but are unsure whether semaglutide, tirzepatide, or another medical weight-loss treatment is right for you, contact Nexel Medical today and take the first step toward a program designed specifically for you.
Both semaglutide and tirzepatide can help appropriate patients achieve significant weight loss, but individual results can vary considerably. Tirzepatide has produced greater average weight loss in some clinical comparisons, but an average result does not tell your provider which medication will work best for you personally. Your starting weight, dosage, length of treatment, eating habits, physical activity, and individual response to medication can all influence your results. The better approach is to choose the medication that fits your needs and then monitor your progress rather than assuming one medication will always produce better results for every patient.
Tirzepatide and semaglutide work differently enough that simply describing one as “stronger” does not tell the whole story. Semaglutide works primarily by activating GLP-1 receptors, while tirzepatide activates both GLP-1 and GIP receptors, giving it an additional pathway through which it can influence appetite, food intake, and metabolism. That difference may help explain why some patients experience greater weight loss with tirzepatide, but other patients do extremely well with semaglutide and have no reason to change treatments. Your provider should look at your response, goals, health history, and tolerance for treatment when deciding which medication offers the better fit.
Patients can sometimes switch from semaglutide to tirzepatide when their healthcare provider believes a change would improve their weight-loss program. A switch might be considered if progress has slowed, weight-loss goals are not being reached, side effects are difficult to manage, or tirzepatide appears to be a better choice based on the patient’s changing needs. However, the medications are not dosed in the same way, so patients should not try to convert their semaglutide dose into a tirzepatide dose on their own. Your provider can determine when to stop one medication, when to begin the other, and which starting dose is appropriate based on your previous treatment and response.
Semaglutide and tirzepatide are generally prescribed as alternative weight-loss therapies rather than medications that are taken together. Both affect the GLP-1 pathway, so using both at the same time is not the usual approach to medical weight loss and could increase the likelihood of unwanted digestive side effects. Instead, your provider will generally select the medication considered most appropriate for your health, goals, and previous treatment experience and then adjust that therapy based on your results. If your current medication stops providing the desired response, changing treatments may be considered rather than simply adding the second medication.
Semaglutide and tirzepatide can cause many of the same types of side effects because both affect appetite and the digestive system. Nausea, diarrhea, constipation, stomach discomfort, and vomiting are among the symptoms patients may experience, particularly when treatment is first started or the dose is increased. However, side effects and their severity can vary greatly from one patient to another, and some people tolerate one medication better than the other. Medical supervision allows your provider to increase the dose gradually when appropriate, monitor how you are responding, and make adjustments that help balance effective weight loss with your ability to remain comfortable on treatment.
* Dosing, administration instructions, warnings, and other product information are provided for informational purposes only and should not be construed as any kind of medical guidance or instructions for use. Consult your physician pharmacist or complete prescribing information for advice regarding your prescription for Semaglutide or Tirzepatide.
** Prices for prescription drugs are subject to change. Prices provided are for relative comparison purposes only and may not be a reflection of the actual cost of either drug at the time of purchase.
Complete The Short Form Below To Contact a Nexel Medical Physician
